Drugs / E. coli strain Nissle 1917
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02802059 | Oct 2015 → Oct 2020 | infectious disease | Ardeypharm GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E. coli strain Nissle 1917 | “E. coli strain Nissle 1917 bacteria” NCT02802059 ↗ |
| Known as | EcN-Suspension | “E. coli strain Nissle 1917 (EcN-Suspension) probiotic bacteria administration” NCT02802059 ↗ |
| Modality | Other / unclassified | “EcN-Suspension probiotic bacteria” NCT02802059 ↗ |